Transcatheter Tricuspid Valve Replacement Using the Lux-Valve Plus System

NAEnrolling by invitationINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 18, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Tricuspid Regurgitation
Interventions
DEVICE

LuxValve PLlus

The LuX-Valve (Jenscare Biotechnology) is a radial force-independent orthotopic TTVR device. The feasibility and efficacy of this device have been reported by several studies (11-13). However, this valve was implanted through right atrial access, where a small incision of the right chest and right atrium is needed. The LuX-Valve Plus valve replacement system is the second-generation version of the LuX-Valve and can be implanted through the jugular vein.

Trial Locations (1)

0000

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Prince of Wales Hospital, Shatin, Hong Kong

OTHER